Evaluation of rejuvenating effect of cell culture media cosmetics containing allogenic dermal ECM after Fraxel laser treatment

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0007354

Enrollment

Registered

2022-06-03

Start date

2021-10-12

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery, Others(Cosmetics) : After treated with fractional carbon dioxide laser (Edge one, Jeisys, Korea), cosmetics containing allogenic extracellular matrix is applied to one side of face

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged between 20 and 60 years old 2. Featues with facial aing (wrinkles, skin laxity) 3. Those who would write informed consent voluntarily 4. Those who could follow the clinical trial procedure

Exclusion criteria

Exclusion criteria: - a history of allergic contact dermatitis to cosmetics or EMLA cream (2.5% lidocaine and 2.5 prilocaine) - a history of atopic dermatitis or other facial dermatitis - a history of keloid, or signs of skin infection or inflammation - who underwent facial rejuvenating procedures within six months - pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
in vivo skin measurement using ANTERA	—

Secondary

Measure	Time frame
Investigator's global assessment	—

Countries

Korea, Republic of

Contacts

Public ContactSoon-Hyo Kwon

Kyung Hee University Hospital at Gangdong

soonhyo17@hanmail.net+82-2-440-7329

Outcome results